Of note, D1143 augments the tumor-specific adaptive immunity induced by ablative radiation therapy, while reducing host immunosuppressive cell infiltrates in the tumor microenvironment in a TNFα, IFNγ and CD8+ T-cell-dependent manner [48]. The gene discussed is TNF; the disease is neoplasm.